| 注册
首页|期刊导航|广州医药|MDSCs调控新生儿免疫应答机制及其临床意义

MDSCs调控新生儿免疫应答机制及其临床意义

徐凝 王丽娜 刘国成 刘雨丰

广州医药2024,Vol.55Issue(5):457-462,6.
广州医药2024,Vol.55Issue(5):457-462,6.DOI:10.3969/j.issn.1000-8535.2024.05.002

MDSCs调控新生儿免疫应答机制及其临床意义

Mechanism and clinical significance of MDSCs regulation of neonatal immune response

徐凝 1王丽娜 2刘国成 1刘雨丰3

作者信息

  • 1. 广东省妇幼保健院产科(广东广州 511442)
  • 2. 广州市第一人民医院儿科(广东广州 510180)
  • 3. 广州市第一人民医院医学研究与创新转化中心(广东广州 510320)
  • 折叠

摘要

Abstract

The developmental stage of the immune system during the neonatal period is crucial for maintaining neonatal health,characterized by unique immunoregulatory mechanisms.In recent years,increasing attention has been drawn to the role of myeloid-derived suppressor cells(MDSCs)in neonatal immune regulation.MDSCs represents a heterogeneous population of cells with potent immunosuppressive functions,capable of modulating immune responses through various mechanisms.The regulatory role of MDSCs in neonates is vital for preventing excessive immune reactions and promoting immune tolerance,thereby aiding in the prevention of neonatal inflammatory diseases and positively influencing subsequent health outcomes.Analysis of recent research literature reveals multiple mechanisms through which MDSCs contribute to neonatal immune regulation,including protective effects under specific pathological conditions,interactions with neonatal inflammatory responses,and potential impacts on long-term immune development.Therefore,a comprehensive understanding of the role of MDSCs in neonatal immunity not only helps elucidate their intricate regulatory mechanisms but also provides novel insights for developing strategies for the prevention and treatment of neonatal inflammatory diseases.

关键词

新生儿/髓源性抑制细胞/免疫调节

Key words

newborn/myeloid-derived suppressor cells(MDSCs)/immune regulation

引用本文复制引用

徐凝,王丽娜,刘国成,刘雨丰..MDSCs调控新生儿免疫应答机制及其临床意义[J].广州医药,2024,55(5):457-462,6.

基金项目

国家自然科学基金面上项目(8217060280) (8217060280)

广州市校(院)企联合资助项目(SL2024A03J01319) (院)

广东省基础与应用基础研究专题(优秀博士"续航"项目)(SL2024A04J00240) (优秀博士"续航"项目)

广州医药

1000-8535

访问量0
|
下载量0
段落导航相关论文